CD8A and cancer: Finally, TCRs on CD8+ T cells recognize the antigenic peptide-MHC-I complex and kills target cancer cells, with antigens released by dead cancer cells into the next cycle (30) The potential alterations regulated by arginine methylation in cancer-immunity cycle are shown (Figure 2).